LY4065967 for Knee Pain from Osteoarthritis
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
- Age
- 40 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Eli Lilly and Company · Industry
This trial is looking for people with knee pain from osteoarthritis to test a new treatment. Participants will need to meet specific health criteria to join the study.
You may be able to join if
- I have knee pain for more than 12 weeks.
- I have an x-ray showing osteoarthritis in my knee.
- I have a body mass index of 40 or less.
- I have stable blood sugar levels.
You may not be able to join if
- I am pregnant or breastfeeding.
- I have had surgery or an injection in my knee in the last 3 months.
- I have any foreign object in my knee.
- I have a complex pain condition that affects my knee pain assessment.
- I have had any lower leg joint replacement in the last 6 months.
- I have high blood pressure.
- I have significant heart disease or rhythm problems.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Loading trial locations…
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
1-317-615-4559
CONTACT
Physicians interested in becoming principal investigators please contact
clinical_inquiry_hub@lilly.com
CONTACT